India is ready to give priority to Sri Lanka when supplying to other countries the vaccine now being produced by India to treat COVID 19 virus, the External Affairs Minister of India Dr. S. Jaishankar told President Gotabaya Rajapaksa.
Arrived yesterday in the country for a two-day visit, the Indian Minister called on President Rajapaksa at the Presidential Secretariat yesterday (6).
Commenting on the future course of action to control the COVID 19 pandemic during the ensuing discussion President stated that Sri Lanka would like to obtain the COVID vaccine, which is being produced by India following an accurate assessment of the need for treatment.
“We are now looking at post-COVID cooperation and I carry back with me Sri Lanka’s interest in accessing vaccines from India,” said Jaishankar.
Both President and the Indian Minister agreed to further enhance Indo – Sri Lanka bilateral relations so as to maximize mutual benefits.
India’s drug regulator has approved two vaccines for emergency use for COVID-19 – one developed by Oxford University and United Kingdom-based drug maker AstraZeneca, and another by the Indian manufacturer Bharat Biotech.
Serum Institute of India, the world’s largest vaccine manufacturing company, has been contracted by AstraZeneca to make one billion doses for developing nations, including India.
(source – president media division / Aljazeera)